Ramzy Yassa / N. P. V. Nair / Dilip V. Jeste (eds.)
Neuroleptic-Induced Movement Disorders
A Comprehensive Survey
Herausgeber: Jeste, Dilip V.; Yassa, Ramzy; Nair, N. P. V.
Ramzy Yassa / N. P. V. Nair / Dilip V. Jeste (eds.)
Neuroleptic-Induced Movement Disorders
A Comprehensive Survey
Herausgeber: Jeste, Dilip V.; Yassa, Ramzy; Nair, N. P. V.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Deals with historical, clinical and neurobiological aspects of movement disorders commonly associated with neuroleptic drugs.
Andere Kunden interessierten sich auch für
![Stahl's Illustrated Mood Stabilizers]( "Stahl's Illustrated Mood Stabilizers")
Stephen M. StahlStahl's Illustrated Mood Stabilizers55,99 €![Through the Gateway of the Heart, Second Edition]( "Through the Gateway of the Heart, Second Edition")
Sophia AdamsonThrough the Gateway of the Heart, Second Edition22,99 €![The Match]( "The Match")
Alfred a BorrelliThe Match19,99 €![Liquid Conspiracy 2: The Cia, Mi5 and Big Pharma's War on Psychedelics]( "Liquid Conspiracy 2: The Cia, Mi5 and Big Pharma's War on Psychedelics")
Xaviant HazeLiquid Conspiracy 2: The Cia, Mi5 and Big Pharma's War on Psychedelics17,99 €![Anxiety Disorders]( "Anxiety Disorders")
Anxiety Disorders62,99 €![Finding Kali]( "Finding Kali")
Kali Rae WheelerFinding Kali18,99 €![Drug Metabolism in Psychiatry]( "Drug Metabolism in Psychiatry")
Daniel J CarlatDrug Metabolism in Psychiatry41,99 €-
-
-
Deals with historical, clinical and neurobiological aspects of movement disorders commonly associated with neuroleptic drugs.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 516
- Erscheinungstermin: 29. Dezember 2006
- Englisch
- Abmessung: 229mm x 152mm x 30mm
- Gewicht: 829g
- ISBN-13: 9780521033527
- ISBN-10: 0521033527
- Artikelnr.: 22580016
- Verlag: Cambridge University Press
- Seitenzahl: 516
- Erscheinungstermin: 29. Dezember 2006
- Englisch
- Abmessung: 229mm x 152mm x 30mm
- Gewicht: 829g
- ISBN-13: 9780521033527
- ISBN-10: 0521033527
- Artikelnr.: 22580016
Contributors; Preface; Part I. Historical Perspective: 1.
Neuroleptic-induced movement disorders: historical perspective Marc-Alain
Wolf, Ramzy Yassa and Pierre-Michel Llorca; Part II. Clinical Aspects of
Tardive Dyskinesia: 2. Aging and tardive dyskinesia Bruce L. Saltz, John M.
Kane, Margaret G. Woerner, Jeffrey A. Lieberman and José Ma. J. Alvir; 3.
Gender as a factor in the development of tardive dyskinesia Ramzy Yassa and
Dilip V. Jeste; 4. The Yale tardive dyskinesia study: a prospective
incidence study among long-term outpatients William M. Glazer, Hal
Morgenstern, Donna Raye Wagner and John Doucette; 5. Vulnerability to
tardive dyskinesia in schizophrenia: an exploration of individual patient
factors John L. Waddington, Eadbhard O'Callaghan, Peter Buckely, Cathy
Madigan, Conall Larkin and Anthony Kinsella; 6. Tardive dyskinesia and
affective disorder George Gardos and Jonathan O. Cole; 7. Diabetes mellitus
and tardive dyskinesia Sukdeb Mukherjee and Sahebarao P. Mahadik; 8. Other
factors in the development of tardive dyskinesia Ramzy Yassa; 9.
Neuroleptic treatment and tardive dyskinesia George Gardos and Jonathan O.
Cole; 10. Anticholinergic drugs as factors in the development of tardive
dyskinesia Ramzy Yassa and N. P. V. Nair; Part III. Mechanisms Underlying
Tardive Dyskinesia: 11. Neurochemistry of the basal ganglia N. P. V. Nair
and T. E. G. West; 12. A reanalysis of the dopamine theory of tardive
dyskinesia: the hypothesis of dopamine D1/D2 imbalance Linda Peacock and
Jes Gerlach; 13. Tardive dyskinesia and phenylalanine metabolism:
risk-factor studies Mary Ann Richardson, Cheryl Flynn, Laura Read, Margaret
Reilly and Raymond Suckow; 14. Neuroendocrinological studies of tardive
dyskinesia Margot Albus; 15. Cognitive deficits and tardive dyskinesia
Marion E. Wolf, Alan S. DeWolfe and Aron D. Mosnaim; 16. Studies of tardive
dyskinesia using computed tomography and magnetic-resonance imaging
Christian L. Shriqui; 17. Rodent and other animal models of tardive
dyskinesia during long-term neuroleptic-drug administration: controversies
and implications for the clinical syndrome John L. Waddington; Part IV.
Measurement of Tardive Dyskinesia: 18. Instrument measurements of tardive
dyskinesia Michael P. Caligiuri; Part V. Tardive Dyskinesia in Different
Populations: 19. Cultural aspects of tardive dyskinesia in Asia Shigeto
Yamawaki, Teruo Hayashi; Ikuo Nagaoka, Hiroshi Saitoh, Norio Yokota and
Yosuke Uchitomi; 20. Tardive dyskinesia in North America and the Middle
East Driss Moussaoui; 21. Tardive dyskinesia in Europe H. A. McClelland and
T. A. Kerr; 22. Role of ethnicity in the development of tardive dyskinesia
Jonathan P. Lacro and Dilip V. Jeste; 23. Tardive dyskinesia in children
and adolescents Mark Magulac and Dilip V. Jeste; Part VI. Other
Neuropleptic-Induced Movement Disorders: 24. Drug-induced parkinsonism
Thomas E. Hansen and William F. Hoffman; 25. Clinical aspects of
neuroleptic-induced dystonia George A. Keepers and Linda Ganzini; 26.
Tardive dystonia Paul Greene; 27. Tardive akathisia Robert E. Burke; Part
VII. Treatment of Tardive Dyskinesia: 28. Development of novel
antipsychotic drugs with reduced extrapyramidal side effects Allan Z.
Safferman, Jeffrey A. Lieberman, Bruce J. Kinon, Daniel Umbricht, Jeffrey
S. Aronowitz and John M. Kane; 29. GABAergic treatments for tardive
dyskinesia Shawn L. Cassady, Gunvant K. Thaker and Carol A. Tamminga; 30.
Using biofeedback to train suppression of the oral-lingual movements of
tardive dyskinesia Ronald C. Fudge and Cecile E. Sison; Index.
Neuroleptic-induced movement disorders: historical perspective Marc-Alain
Wolf, Ramzy Yassa and Pierre-Michel Llorca; Part II. Clinical Aspects of
Tardive Dyskinesia: 2. Aging and tardive dyskinesia Bruce L. Saltz, John M.
Kane, Margaret G. Woerner, Jeffrey A. Lieberman and José Ma. J. Alvir; 3.
Gender as a factor in the development of tardive dyskinesia Ramzy Yassa and
Dilip V. Jeste; 4. The Yale tardive dyskinesia study: a prospective
incidence study among long-term outpatients William M. Glazer, Hal
Morgenstern, Donna Raye Wagner and John Doucette; 5. Vulnerability to
tardive dyskinesia in schizophrenia: an exploration of individual patient
factors John L. Waddington, Eadbhard O'Callaghan, Peter Buckely, Cathy
Madigan, Conall Larkin and Anthony Kinsella; 6. Tardive dyskinesia and
affective disorder George Gardos and Jonathan O. Cole; 7. Diabetes mellitus
and tardive dyskinesia Sukdeb Mukherjee and Sahebarao P. Mahadik; 8. Other
factors in the development of tardive dyskinesia Ramzy Yassa; 9.
Neuroleptic treatment and tardive dyskinesia George Gardos and Jonathan O.
Cole; 10. Anticholinergic drugs as factors in the development of tardive
dyskinesia Ramzy Yassa and N. P. V. Nair; Part III. Mechanisms Underlying
Tardive Dyskinesia: 11. Neurochemistry of the basal ganglia N. P. V. Nair
and T. E. G. West; 12. A reanalysis of the dopamine theory of tardive
dyskinesia: the hypothesis of dopamine D1/D2 imbalance Linda Peacock and
Jes Gerlach; 13. Tardive dyskinesia and phenylalanine metabolism:
risk-factor studies Mary Ann Richardson, Cheryl Flynn, Laura Read, Margaret
Reilly and Raymond Suckow; 14. Neuroendocrinological studies of tardive
dyskinesia Margot Albus; 15. Cognitive deficits and tardive dyskinesia
Marion E. Wolf, Alan S. DeWolfe and Aron D. Mosnaim; 16. Studies of tardive
dyskinesia using computed tomography and magnetic-resonance imaging
Christian L. Shriqui; 17. Rodent and other animal models of tardive
dyskinesia during long-term neuroleptic-drug administration: controversies
and implications for the clinical syndrome John L. Waddington; Part IV.
Measurement of Tardive Dyskinesia: 18. Instrument measurements of tardive
dyskinesia Michael P. Caligiuri; Part V. Tardive Dyskinesia in Different
Populations: 19. Cultural aspects of tardive dyskinesia in Asia Shigeto
Yamawaki, Teruo Hayashi; Ikuo Nagaoka, Hiroshi Saitoh, Norio Yokota and
Yosuke Uchitomi; 20. Tardive dyskinesia in North America and the Middle
East Driss Moussaoui; 21. Tardive dyskinesia in Europe H. A. McClelland and
T. A. Kerr; 22. Role of ethnicity in the development of tardive dyskinesia
Jonathan P. Lacro and Dilip V. Jeste; 23. Tardive dyskinesia in children
and adolescents Mark Magulac and Dilip V. Jeste; Part VI. Other
Neuropleptic-Induced Movement Disorders: 24. Drug-induced parkinsonism
Thomas E. Hansen and William F. Hoffman; 25. Clinical aspects of
neuroleptic-induced dystonia George A. Keepers and Linda Ganzini; 26.
Tardive dystonia Paul Greene; 27. Tardive akathisia Robert E. Burke; Part
VII. Treatment of Tardive Dyskinesia: 28. Development of novel
antipsychotic drugs with reduced extrapyramidal side effects Allan Z.
Safferman, Jeffrey A. Lieberman, Bruce J. Kinon, Daniel Umbricht, Jeffrey
S. Aronowitz and John M. Kane; 29. GABAergic treatments for tardive
dyskinesia Shawn L. Cassady, Gunvant K. Thaker and Carol A. Tamminga; 30.
Using biofeedback to train suppression of the oral-lingual movements of
tardive dyskinesia Ronald C. Fudge and Cecile E. Sison; Index.
Contributors; Preface; Part I. Historical Perspective: 1.
Neuroleptic-induced movement disorders: historical perspective Marc-Alain
Wolf, Ramzy Yassa and Pierre-Michel Llorca; Part II. Clinical Aspects of
Tardive Dyskinesia: 2. Aging and tardive dyskinesia Bruce L. Saltz, John M.
Kane, Margaret G. Woerner, Jeffrey A. Lieberman and José Ma. J. Alvir; 3.
Gender as a factor in the development of tardive dyskinesia Ramzy Yassa and
Dilip V. Jeste; 4. The Yale tardive dyskinesia study: a prospective
incidence study among long-term outpatients William M. Glazer, Hal
Morgenstern, Donna Raye Wagner and John Doucette; 5. Vulnerability to
tardive dyskinesia in schizophrenia: an exploration of individual patient
factors John L. Waddington, Eadbhard O'Callaghan, Peter Buckely, Cathy
Madigan, Conall Larkin and Anthony Kinsella; 6. Tardive dyskinesia and
affective disorder George Gardos and Jonathan O. Cole; 7. Diabetes mellitus
and tardive dyskinesia Sukdeb Mukherjee and Sahebarao P. Mahadik; 8. Other
factors in the development of tardive dyskinesia Ramzy Yassa; 9.
Neuroleptic treatment and tardive dyskinesia George Gardos and Jonathan O.
Cole; 10. Anticholinergic drugs as factors in the development of tardive
dyskinesia Ramzy Yassa and N. P. V. Nair; Part III. Mechanisms Underlying
Tardive Dyskinesia: 11. Neurochemistry of the basal ganglia N. P. V. Nair
and T. E. G. West; 12. A reanalysis of the dopamine theory of tardive
dyskinesia: the hypothesis of dopamine D1/D2 imbalance Linda Peacock and
Jes Gerlach; 13. Tardive dyskinesia and phenylalanine metabolism:
risk-factor studies Mary Ann Richardson, Cheryl Flynn, Laura Read, Margaret
Reilly and Raymond Suckow; 14. Neuroendocrinological studies of tardive
dyskinesia Margot Albus; 15. Cognitive deficits and tardive dyskinesia
Marion E. Wolf, Alan S. DeWolfe and Aron D. Mosnaim; 16. Studies of tardive
dyskinesia using computed tomography and magnetic-resonance imaging
Christian L. Shriqui; 17. Rodent and other animal models of tardive
dyskinesia during long-term neuroleptic-drug administration: controversies
and implications for the clinical syndrome John L. Waddington; Part IV.
Measurement of Tardive Dyskinesia: 18. Instrument measurements of tardive
dyskinesia Michael P. Caligiuri; Part V. Tardive Dyskinesia in Different
Populations: 19. Cultural aspects of tardive dyskinesia in Asia Shigeto
Yamawaki, Teruo Hayashi; Ikuo Nagaoka, Hiroshi Saitoh, Norio Yokota and
Yosuke Uchitomi; 20. Tardive dyskinesia in North America and the Middle
East Driss Moussaoui; 21. Tardive dyskinesia in Europe H. A. McClelland and
T. A. Kerr; 22. Role of ethnicity in the development of tardive dyskinesia
Jonathan P. Lacro and Dilip V. Jeste; 23. Tardive dyskinesia in children
and adolescents Mark Magulac and Dilip V. Jeste; Part VI. Other
Neuropleptic-Induced Movement Disorders: 24. Drug-induced parkinsonism
Thomas E. Hansen and William F. Hoffman; 25. Clinical aspects of
neuroleptic-induced dystonia George A. Keepers and Linda Ganzini; 26.
Tardive dystonia Paul Greene; 27. Tardive akathisia Robert E. Burke; Part
VII. Treatment of Tardive Dyskinesia: 28. Development of novel
antipsychotic drugs with reduced extrapyramidal side effects Allan Z.
Safferman, Jeffrey A. Lieberman, Bruce J. Kinon, Daniel Umbricht, Jeffrey
S. Aronowitz and John M. Kane; 29. GABAergic treatments for tardive
dyskinesia Shawn L. Cassady, Gunvant K. Thaker and Carol A. Tamminga; 30.
Using biofeedback to train suppression of the oral-lingual movements of
tardive dyskinesia Ronald C. Fudge and Cecile E. Sison; Index.
Neuroleptic-induced movement disorders: historical perspective Marc-Alain
Wolf, Ramzy Yassa and Pierre-Michel Llorca; Part II. Clinical Aspects of
Tardive Dyskinesia: 2. Aging and tardive dyskinesia Bruce L. Saltz, John M.
Kane, Margaret G. Woerner, Jeffrey A. Lieberman and José Ma. J. Alvir; 3.
Gender as a factor in the development of tardive dyskinesia Ramzy Yassa and
Dilip V. Jeste; 4. The Yale tardive dyskinesia study: a prospective
incidence study among long-term outpatients William M. Glazer, Hal
Morgenstern, Donna Raye Wagner and John Doucette; 5. Vulnerability to
tardive dyskinesia in schizophrenia: an exploration of individual patient
factors John L. Waddington, Eadbhard O'Callaghan, Peter Buckely, Cathy
Madigan, Conall Larkin and Anthony Kinsella; 6. Tardive dyskinesia and
affective disorder George Gardos and Jonathan O. Cole; 7. Diabetes mellitus
and tardive dyskinesia Sukdeb Mukherjee and Sahebarao P. Mahadik; 8. Other
factors in the development of tardive dyskinesia Ramzy Yassa; 9.
Neuroleptic treatment and tardive dyskinesia George Gardos and Jonathan O.
Cole; 10. Anticholinergic drugs as factors in the development of tardive
dyskinesia Ramzy Yassa and N. P. V. Nair; Part III. Mechanisms Underlying
Tardive Dyskinesia: 11. Neurochemistry of the basal ganglia N. P. V. Nair
and T. E. G. West; 12. A reanalysis of the dopamine theory of tardive
dyskinesia: the hypothesis of dopamine D1/D2 imbalance Linda Peacock and
Jes Gerlach; 13. Tardive dyskinesia and phenylalanine metabolism:
risk-factor studies Mary Ann Richardson, Cheryl Flynn, Laura Read, Margaret
Reilly and Raymond Suckow; 14. Neuroendocrinological studies of tardive
dyskinesia Margot Albus; 15. Cognitive deficits and tardive dyskinesia
Marion E. Wolf, Alan S. DeWolfe and Aron D. Mosnaim; 16. Studies of tardive
dyskinesia using computed tomography and magnetic-resonance imaging
Christian L. Shriqui; 17. Rodent and other animal models of tardive
dyskinesia during long-term neuroleptic-drug administration: controversies
and implications for the clinical syndrome John L. Waddington; Part IV.
Measurement of Tardive Dyskinesia: 18. Instrument measurements of tardive
dyskinesia Michael P. Caligiuri; Part V. Tardive Dyskinesia in Different
Populations: 19. Cultural aspects of tardive dyskinesia in Asia Shigeto
Yamawaki, Teruo Hayashi; Ikuo Nagaoka, Hiroshi Saitoh, Norio Yokota and
Yosuke Uchitomi; 20. Tardive dyskinesia in North America and the Middle
East Driss Moussaoui; 21. Tardive dyskinesia in Europe H. A. McClelland and
T. A. Kerr; 22. Role of ethnicity in the development of tardive dyskinesia
Jonathan P. Lacro and Dilip V. Jeste; 23. Tardive dyskinesia in children
and adolescents Mark Magulac and Dilip V. Jeste; Part VI. Other
Neuropleptic-Induced Movement Disorders: 24. Drug-induced parkinsonism
Thomas E. Hansen and William F. Hoffman; 25. Clinical aspects of
neuroleptic-induced dystonia George A. Keepers and Linda Ganzini; 26.
Tardive dystonia Paul Greene; 27. Tardive akathisia Robert E. Burke; Part
VII. Treatment of Tardive Dyskinesia: 28. Development of novel
antipsychotic drugs with reduced extrapyramidal side effects Allan Z.
Safferman, Jeffrey A. Lieberman, Bruce J. Kinon, Daniel Umbricht, Jeffrey
S. Aronowitz and John M. Kane; 29. GABAergic treatments for tardive
dyskinesia Shawn L. Cassady, Gunvant K. Thaker and Carol A. Tamminga; 30.
Using biofeedback to train suppression of the oral-lingual movements of
tardive dyskinesia Ronald C. Fudge and Cecile E. Sison; Index.